| Code | Description | Claims | Beneficiaries | Total Paid |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,203 |
3,734 |
$393K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,954 |
3,489 |
$297K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
524 |
429 |
$219K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,293 |
4,034 |
$204K |
| A0425 |
Ground mileage, per statute mile |
1,161 |
911 |
$184K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
829 |
774 |
$69K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,499 |
1,364 |
$41K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
782 |
743 |
$36K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
771 |
729 |
$30K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
158 |
133 |
$28K |
| 80053 |
Comprehensive metabolic panel |
814 |
748 |
$20K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
178 |
173 |
$18K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
232 |
222 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
253 |
243 |
$12K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
13 |
12 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
1,684 |
1,476 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
214 |
124 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
436 |
414 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
259 |
240 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
86 |
75 |
$3K |
| 86480 |
|
61 |
51 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
54 |
50 |
$2K |
| 87081 |
|
206 |
193 |
$2K |
| 80061 |
Lipid panel |
488 |
454 |
$2K |
| 81001 |
|
70 |
62 |
$1K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
97 |
95 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
26 |
26 |
$1K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12 |
12 |
$767.04 |
| 86140 |
|
31 |
27 |
$744.17 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
16 |
14 |
$220.96 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14 |
12 |
$165.62 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
12 |
12 |
$63.38 |